In vitro and in vivo metabolism profiles of cathinone and pseudoephedrine: Discrimination between khat and pseudoephedrine uses
Related Experiment Video
Updated: Mar 19, 2026

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
Published on: March 28, 2017
Jong Suk Park1, Jun Sang Yu1,2, Yejin Kim1
1Pharmacomicrobiomics Research Center and College of Pharmacy, Hanyang University, Ansan, Gyeonggi-do, Korea.
Abstract:
In the present study, the metabolism of khat (Catha edulis) and pseudoephedrine was compared with the aim of identifying objective criteria that could be used to discriminate between them for forensic and doping-control purposes. An in vitro study using human liver microsomes and an in vivo study using rat urine were performed under harmonized experimental conditions. Biological samples were analyzed by liquid chromatography-tandem mass spectrometry, and the resulting metabolism profiles were qualitatively and semi-quantitatively compared. Several metabolites of khat (or cathinone) and pseudoephedrine were common in both models, confirming that cathine alone cannot serve as a specific marker of khat use. Cathinone was also detected in pseudoephedrine-treated rat urine, although only at very low concentrations, while the unchanged parent compound remained the predominant urinary species in both dosing conditions. Thus, these findings indicate that interpretation must rely on the overall parent-metabolite pattern and support the use of urinary pseudoephedrine-to-cathinone concentration ratios as tentative criteria to discriminate between khat and pseudoephedrine use.
More Related Videos
06:06Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones
Published on: February 5, 2018
13:35A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites
Published on: March 1, 2018
Related Concept Videos
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Pharmacogenetics of Drug Metabolism: Overview
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
Pharmacokinetics in Pediatric Patients: Drug Metabolism